Clinical Research Directory
Browse clinical research sites, groups, and studies.
Hyperbaric Oxygen Therapy for Post-COVID-19 Syndrome
Sponsor: Assaf-Harofeh Medical Center
Summary
Post-COVID-19 syndrome is an assembly of symptoms, following an infection with Coronavirus disease 2019 (COVID-19). The syndrome is characterized by cognitive impairment, fatigue, sleep disorders, smell and taste disorders, pain and more. This long-term sequela can last for months after recovering from the virus, and no treatment is known to date. The aim of this study is to compare the effect of HBOT vs. Sham on post COVID-19 syndrome
Official title: Hyperbaric Oxygen Therapy for Post-COVID-19 Syndrome: a Prospective, Randomized, Double Blind Study.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
91
Start Date
2023-06-01
Completion Date
2027-12-31
Last Updated
2026-04-21
Healthy Volunteers
No
Conditions
Interventions
Hyperbaric oxygen
Each session will include exposure of 90 minutes to 100% at 2 ATA, with 5 minutes air breaks every 20 minutes
Sham
Each session will include exposure of 90 minutes to 21% at 1.2 ATA during the first five minutes of the session with the noise of circulating air, and then decrease slowly during the next five minutes to 1.03 ATA
Locations (1)
Assaf-Harofeh medical center
Ẕerifin, Israel